| Year |
Citation |
Score |
| 2020 |
Nazha B, Goyal S, Chen Z, Engelhart A, Carlisle JW, Beardslee TJ, Gill H, Odikadze L, Liu Y, Mishra MK, Ramalingam SS, Owonikoko TK. Efficacy and safety of immune checkpoint blockade in self-identified black patients with advanced non-small cell lung cancer. Cancer. PMID 32902858 DOI: 10.1002/Cncr.33141 |
0.364 |
|
| 2020 |
Harvey RD, Carthon BC, Lewis C, Hossain MS, Zhang C, Chen Z, Harris WB, Alese OB, Shaib W, Bilen MA, Lawson DH, Wu C, Steuer CE, El-Rayes BF, Khuri FR, et al. Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. British Journal of Cancer. PMID 32704173 DOI: 10.1038/S41416-020-0988-2 |
0.321 |
|
| 2020 |
Owonikoko TK, Harvey RD, Carthon B, Chen Z, Lewis C, Collins H, Zhang C, Lawson DH, Alese OB, Bilen MA, Sica GL, Steuer CE, Shaib WL, Wu C, Harris WB, et al. A Phase I study of safety, pharmacokinetics, and pharmacodynamics of concurrent everolimus and buparlisib treatment in advanced solid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32005746 DOI: 10.1158/1078-0432.Ccr-19-2697 |
0.308 |
|
| 2020 |
Sahin IH, Goyal S, Pumpalova YS, Sonbol MB, Das S, Haraldsdottir S, Chen Z, Akce M, Alese OB, Shaib WL, Ahn DH, Ciombor KK, Berlin J, Bekaii-Saab TS, Draper A, et al. Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts). Journal of Clinical Oncology. 38: 225-225. DOI: 10.1200/Jco.2020.38.4_Suppl.225 |
0.301 |
|
| 2020 |
McCabe C, Patel U, Beardslee T, Caulfield S, Lee C, Pruitt R, Chen Z, Goyal S, Draper A, Shaib WL. The impact of body mass index (BMI) on the safety and outcomes of small molecule inhibitors (SMI) in gastrointestinal cancer. Journal of Clinical Oncology. 38: 144-144. DOI: 10.1200/Jco.2020.38.4_Suppl.144 |
0.314 |
|
| 2020 |
Higgins JP, Lalonde C, Byers KF, Davis C, Horne K, Goyal S, Chen Z, Meisel JL, Kramer JL, Barbee MS. Gemcitabine with carboplatin in metastatic breast cancer: Characterizing outcomes in a modern, real-world population. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E13085 |
0.304 |
|
| 2020 |
Owonikoko TK, Dwivedi B, Chen Z, Zhang C, Barwick B, Gilbert-Ross M, Ernani V, Barwick B, Zhang G, Carlisle JW, Khuri FR, Curran WJ, Lonial S, Ramalingam SS, Sun S, et al. YAP1 positive small-cell lung cancer subtype is associated with the T-cell inflamed gene expression profile and confers good prognosis and long term survival. Journal of Clinical Oncology. 38: 9019-9019. DOI: 10.1200/Jco.2020.38.15_Suppl.9019 |
0.328 |
|
| 2019 |
Saba NF, Force S, Staley C, Fernandez F, Willingham F, Pickens A, Cardona K, Chen Z, Goff L, Cardin D, Lambright E, Nesbitt J, Krasinskas A, Higgins K, Harvey RD, et al. Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal Cancer. American Journal of Clinical Oncology. PMID 30789414 DOI: 10.1097/Coc.0000000000000524 |
0.32 |
|
| 2019 |
Paplomata E, Zelnak A, Santa-Maria CA, Liu Y, Gogineni K, Li X, Moreno CS, Chen Z, Kaklamani V, O'Regan RM. Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer. Clinical Breast Cancer. PMID 30745109 DOI: 10.1016/J.Clbc.2018.12.017 |
0.304 |
|
| 2019 |
Sahin IH, Chen WH, Chen Z, Akce M, Alese OB, Shaib WL, El-Rayes BF, Wu C. Impact of genomic alterations (GAs) on outcomes and their distribution by age groups in metastatic colorectal cancer (mCRC) patients (pts). Journal of Clinical Oncology. 37: 560-560. DOI: 10.1200/Jco.2019.37.4_Suppl.560 |
0.302 |
|
| 2019 |
Sahin IH, Chen W, Sonbol MB, Das S, Chen Z, Akce M, Alese OB, Shaib WL, Ahn DH, Ciombor KK, Borad MJ, Berlin J, Bekaii-Saab TS, Draper A, El-Rayes BF, et al. Analysis of age, tumor-sidedness, and mismatch repair (MMR) genes with response to immune checkpoint inhibitors (ICIs) in MMR-deficient (dMMR) colorectal cancer (CRC) patients (pts): A multi-institutional study. Journal of Clinical Oncology. 37: e15029-e15029. DOI: 10.1200/Jco.2019.37.15_Suppl.E15029 |
0.308 |
|
| 2019 |
Nazha B, Chen Z, Goyal S, Engelhart A, Carlisle JW, Beardslee T, Gill H, Odikadze L, Liu Y, Mishra MK, Behera M, Ramalingam SS, Owonikoko TK. Evaluating the role of race in outcome of advanced non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitor (ICI): Our institutional experience. Journal of Clinical Oncology. 37: 9042-9042. DOI: 10.1200/Jco.2019.37.15_Suppl.9042 |
0.362 |
|
| 2019 |
Owonikoko TK, Higgins KA, Chen Z, Zhang C, Pillai RN, Steuer CE, Saba NF, Pakkala S, Shin DM, Zhang G, Wang S, Hossain MS, Beardslee T, Engelhart A, Revenig J, et al. A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC). Journal of Clinical Oncology. 37: 8515-8515. DOI: 10.1200/Jco.2019.37.15_Suppl.8515 |
0.386 |
|
| 2019 |
Mao J, Strouse CS, Goldman M, Chen W, Chen Z, Maurer MJ, Calzada O, Churnetski M, Flowers C, Cerhan JR, Link BK, Thompson CA, Cohen JB. Impact on survival of surveillance imaging after first remission in follicular lymphoma. Journal of Clinical Oncology. 37: 7536-7536. DOI: 10.1200/Jco.2019.37.15_Suppl.7536 |
0.303 |
|
| 2019 |
Patel U, Meisel JL, Barbee MS, Frinzi K, Sakach E, Chen Z. The clinical utility of strict laboratory monitoring of CDK 4/6 inhibitors in metastatic breast cancer patients. Journal of Clinical Oncology. 37: 1062-1062. DOI: 10.1200/Jco.2019.37.15_Suppl.1062 |
0.304 |
|
| 2018 |
Lesinski GB, Nannapaneni S, Griffith CC, Patel M, Chen W, Chen Z, Ahmed R, Wieland A, Shin DM, Chen ZG, Saba NF. Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma. Head and Neck Pathology. PMID 30191505 DOI: 10.1007/S12105-018-0962-Y |
0.307 |
|
| 2018 |
Rooney EG, Fleming MM, Patel JG, Clifford K, Kim C, Chen Z, Gillespie TW, Arciero CA, Subhedar PD. Are Lymph Node Characteristics on Axillary Ultrasound Associated with ≥3 Positive Lymph Nodes in Patients Managed by the American College of Surgeons Oncology Group Z0011 Trial Criteria? The American Surgeon. 84: 1133-1137. PMID 30064576 DOI: 10.1177/000313481808400726 |
0.313 |
|
| 2018 |
Wang P, Rahman MA, Zhao Z, Weiss K, Zhang C, Chen Z, Hurwitz SJ, Chen ZG, Shin DM, Ke Y. Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells. Journal of the American Chemical Society. PMID 29406750 DOI: 10.1021/Jacs.7B09024 |
0.303 |
|
| 2018 |
Morgan T, Press RH, Cutrell P, Zhang C, Chen Z, Rahnema S, Sanda MG, Pattaras J, Patel PR, Jani AB, Rossi PJ. Hypofractionated external beam radiation therapy in combination with HDR boost for localized prostate cancer: Quality of life outcomes. Journal of Clinical Oncology. 36: 62-62. DOI: 10.1200/Jco.2018.36.6_Suppl.62 |
0.338 |
|
| 2018 |
Shaib WL, Sayegh L, Alese O, Maithel S, Cardona K, Sarmiento J, Belalcazar A, Ip A, Qu Y, Akce M, Zhang C, Wu CS, Chen Z, El-Rayes BF. Resection of pancreatic cancer following induction chemotherapy. Journal of Clinical Oncology. 36: 406-406. DOI: 10.1200/Jco.2018.36.4_Suppl.406 |
0.375 |
|
| 2018 |
Bernal-Mizrachi L, Cole CE, Heffner L, Nooka AK, Vij R, Kelkar N, Sridhar A, Cinar M, Chen Z, Chang Z, Lonial S, Kaufman JL. Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrangement Driven Trial, PINR) Blood. 132: 2011-2011. DOI: 10.1182/Blood-2018-99-119337 |
0.341 |
|
| 2018 |
Smith DJ, Sauter C, Zhang C, Chen Z, Gogineni K. Abstract B34: Patterns of BRCA testing at a safety net compared to a university hospital Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-B34 |
0.305 |
|
| 2018 |
Chen ZG, Wang D, Griffith CC, Nannapaneni S, Steuer C, Patel MR, El-Deiry MW, Wang X, Zhang Y, Chen Z, Alvarado D, Shin DM, Saba NF. Abstract 876: Effective reduction of PD-L1 expression by simultaneous blockade of EGFR and HER3 (ErbB3) in head and neck cancer Cancer Research. 78: 876-876. DOI: 10.1158/1538-7445.Am2018-876 |
0.324 |
|
| 2017 |
Brutcher EA, Chen Z, Pan A, Barrett T. The Relationship Between Zinc and Quality of Life in Patients With Upper GI Cancer on Chemotherapy. Journal of the Advanced Practitioner in Oncology. 8: 338-345. PMID 30018840 DOI: 10.6004/Jadpro.2017.8.4.3 |
0.32 |
|
| 2017 |
Pokala SK, Zhang C, Chen Z, Gamboa AM, Cristofaro SL, Keilin SA, Cai Q, Willingham FF. Lymph node metastasis in early gastric adenocarcinoma in the United States of America. Endoscopy. PMID 29228402 DOI: 10.1055/S-0043-122379 |
0.32 |
|
| 2017 |
Higgins KA, Pillai RN, Chen Z, Tian S, Zhang C, Patel P, Pakkala S, Shelton J, Force SD, Fernandez FG, Steuer CE, Owonikoko TK, Ramalingam SS, Bradley JD, Curran WJ. Concomitant chemotherapy and radiotherapy with SBRT Boost for Unresectable, Stage III Non-small Cell Lung Cancer: A phase I Study. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28919394 DOI: 10.1016/J.Jtho.2017.07.036 |
0.363 |
|
| 2017 |
Nanda RH, Ganju RG, Schreibmann E, Chen Z, Zhang C, Jegadeesh N, Cassidy R, Deng C, Eaton BR, Esiashvili N. Correlation of Acute and Late Brainstem Toxicities With Dose-Volume Data for Pediatric Patients With Posterior Fossa Malignancies. International Journal of Radiation Oncology, Biology, Physics. 98: 360-366. PMID 28463155 DOI: 10.1016/J.Ijrobp.2017.02.092 |
0.309 |
|
| 2017 |
Gilbert-Ross M, Konen J, Koo J, Shupe J, Robinson BS, Wiles WG, Huang C, Martin WD, Behera M, Smith GH, Hill CE, Rossi MR, Sica GL, Rupji M, Chen Z, et al. Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma. Jci Insight. 2: e90487. PMID 28289710 DOI: 10.1172/Jci.Insight.90487 |
0.333 |
|
| 2017 |
Kong JH, Winton EF, Heffner LT, Chen Z, Langston AA, Hill B, Arellano M, El-Rassi F, Kim A, Jillella A, Kota VK, Bodó I, Khoury HJ. Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia? Cancer. PMID 28241101 DOI: 10.1002/Cncr.30608 |
0.333 |
|
| 2017 |
Chen Z, Li Z, Zhuang R, Yuan Y, Kutner M, Owonikoko T, Curran WJ, Kowalski J. Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic Profile. Plos One. 12: e0170187. PMID 28125617 DOI: 10.1371/Journal.Pone.0170187 |
0.325 |
|
| 2017 |
Goldman ML, Kim C, Chen Z, Calzada O, Churnetski MC, Flowers C, Cohen JB. High-Risk FLIPI Score at Diagnosis Is Associated with Early Relapse in the Rituximab Era for Patients with Follicular Lymphoma Blood. 130: 5158-5158. DOI: 10.1182/Blood.V130.Suppl_1.5158.5158 |
0.309 |
|
| 2017 |
Goldman ML, Kim C, Chen Z, Calzada O, Churnetski MC, Flowers C, Cohen JB. Surveillance Imaging during First-Remission in Follicular Lymphoma Does Not Impact Overall Survival Blood. 130: 1501-1501. DOI: 10.1182/Blood.V130.Suppl_1.1501.1501 |
0.307 |
|
| 2017 |
Wang D, Magliocca KR, Nannapaneni S, Steuer C, Patel MR, El-Deiry MW, Wang X, Chen Z, Shin DM, Saba NF, Chen ZG. Abstract 4110: Combinatory approaches targeting EGFR, HER2 and c-MET in recurrent SCCHN Cancer Research. 77: 4110-4110. DOI: 10.1158/1538-7445.Am2017-4110 |
0.343 |
|
| 2017 |
Rahman MA, Wang P, Wang D, Hurwitz SJ, Chen Z, Chen ZG, Ke Y, Shin DM. Abstract 187: Efficient delivery of Bcl2 siRNA by DNA nanoparticles to inhibit cellular growth and cancer progression Cancer Research. 77: 187-187. DOI: 10.1158/1538-7445.Am2017-187 |
0.339 |
|
| 2017 |
Kim S, Ragin C, Chen Z, Behera M, Pillai R, Steuer C, Belani C, Khuri F, Ramalingam S, Owonikoko T. P1.07-014 Impact of Chemotherapy for Small Cell Lung Cancer in the Third Line and beyond, a SEER-MEDICARE Analysis Journal of Thoracic Oncology. 12: S703-S704. DOI: 10.1016/J.Jtho.2016.11.925 |
0.331 |
|
| 2016 |
Postlewait LM, Ethun CG, Kooby DA, Sarmiento JM, Chen Z, Staley CA, Brutcher E, Adsay V, El-Rayes B, Maithel SK. Combination gemcitabine/cisplatin therapy and ERCC1 expression for resected pancreatic adenocarcinoma: Results of a Phase II prospective trial. Journal of Surgical Oncology. PMID 27501338 DOI: 10.1002/Jso.24317 |
0.354 |
|
| 2016 |
DeFilipp Z, Rosand CB, Goldstein DA, Master VA, Carthon BC, Harris WB, Kucuk O, Al-Kadhimi Z, Cohen JB, Flowers CR, Lechowicz MJ, Nooka AK, Kaufman JL, Langston AA, Chen Z, et al. Comparable outcomes following two or three cycles of high-dose chemotherapy and autologous stem cell transplantation for patients with relapsed/refractory germ cell tumors. Bone Marrow Transplantation. PMID 27427922 DOI: 10.1038/Bmt.2016.189 |
0.315 |
|
| 2016 |
Owonikoko TK, Zhang G, Kim HS, Stinson RM, Bechara R, Zhang C, Chen Z, Saba NF, Pakkala S, Pillai R, Deng X, Sun SY, Rossi MR, Sica GL, Ramalingam SS, et al. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. Journal of Translational Medicine. 14: 111. PMID 27142472 DOI: 10.1186/S12967-016-0861-5 |
0.365 |
|
| 2016 |
Zhang S, Gera L, Mamouni K, Li X, Chen Z, Kucuk O, Wu D. Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644, an aminobisphosphonate derivative. Oncotarget. PMID 27050371 DOI: 10.18632/Oncotarget.8481 |
0.311 |
|
| 2016 |
Chowdry RP, Sica GL, Kim S, Chen Z, Goodman A, Alexis D, Deng X, Owonikoko TK. Phosphorylated Bcl-2 and Mcl-1 as prognostic markers in small cell lung cancer. Oncotarget. PMID 26908449 DOI: 10.18632/Oncotarget.7485 |
0.348 |
|
| 2016 |
Gilbert-Ross M, Konen J, Koo J, Shupe J, Sica GL, Chen Z, Robinson BS, Behera M, Rossi MR, Smith GH, Hill CE, Ramalingam SM, Fu H, Khuri FR, Zhou W, et al. Abstract LB-348: Developing a personalized anti-metastatic therapy to treat KRAS, LKB1-mutant lung adenocarcinoma Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-348 |
0.363 |
|
| 2016 |
Wang D, Qian G, zhang h, Magliocca kR, nannapaneni s, chen z, patel mR, El-Deiry MW, Wadsworth Jt, Shin dM, khuri fR, Saba NF, chen ZG. Abstract 1866: HER3 targeting sensitizes HNSCC to cetuximab - evidence from cell line and patient derived xenograft (PDX) models Cancer Research. 76: 1866-1866. DOI: 10.1158/1538-7445.Am2016-1866 |
0.342 |
|
| 2015 |
Alese OB, Kim S, Chen Z, Shaib W, Staley CA, Ramalingam SS, Owonikoko TK, El-Rayes BF. Management and Outcomes of Hospitalized Patients With Primary Neuroendocrine Tumor and Non-Neuroendocrine Tumor Appendiceal Cancers in the United States. World Journal of Oncology. 6: 349-354. PMID 28983329 DOI: 10.14740/Wjon927W |
0.348 |
|
| 2015 |
Behera M, Ragin C, Kim S, Pillai RN, Chen Z, Steuer CE, Saba NF, Belani CP, Khuri FR, Ramalingam SS, Owonikoko TK. Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005. Cancer. PMID 26441041 DOI: 10.1002/Cncr.29674 |
0.353 |
|
| 2015 |
Shaib WL, Goodman M, Chen Z, Kim S, Brutcher E, Bekaii-Saab T, El-Rayes BF. Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis. American Journal of Clinical Oncology. PMID 26270447 DOI: 10.1097/Coc.0000000000000210 |
0.339 |
|
| 2015 |
Behera M, Pillai RN, Owonikoko TK, Kim S, Steuer C, Chen Z, Saba NF, Belani CP, Khuri FR, Ramalingam SS. Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 10: 1142-7. PMID 26200267 DOI: 10.1097/Jto.0000000000000572 |
0.351 |
|
| 2015 |
Qian G, Jiang N, Wang D, Newman S, Kim S, Chen Z, Garcia G, MacBeath G, Shin DM, Khuri FR, Chen ZG, Saba NF. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma. Cancer. PMID 26195293 DOI: 10.1002/Cncr.29549 |
0.342 |
|
| 2015 |
Shaib WL, Martin LK, Choi M, Chen Z, Krishna K, Kim S, Brutcher E, Staley C, Maithel SK, Philip P, Abdel-Misih S, Bekaii-Saab TS, El-Rayes BF. Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers. The Oncologist. PMID 26070916 DOI: 10.1634/Theoncologist.2014-0294 |
0.325 |
|
| 2015 |
Shaib W, Krishna K, Kim S, Goodman M, Rock J, Chen Z, Brutcher E, Staley CI, Maithel SK, Abdel-Missih S, El-Rayes BF, Bekaii-Saab T. Appendiceal Neuroendocrine, Goblet and Signet-Ring Cell Tumors: A Spectrum of Diseases with Different Patterns of Presentation and Outcome. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 26044156 DOI: 10.4143/Crt.2015.029 |
0.32 |
|
| 2015 |
Chen Z, Yuan Y, Li Z, Kutner M, Owonikoko T, Curran WJ, Khuri F, Kowalski J. Dose escalation with over-dose and under-dose controls in Phase I/II clinical trials. Contemporary Clinical Trials. 43: 133-41. PMID 26012358 DOI: 10.1016/J.Cct.2015.05.014 |
0.303 |
|
| 2015 |
Alese OB, El-Rayes BF, Sica G, Zhang G, Alexis D, La Rosa FG, Varella-Garcia M, Chen Z, Rossi MR, Adsay NV, Khuri FR, Owonikoko TK. Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract. Therapeutic Advances in Medical Oncology. 7: 56-62. PMID 25755678 DOI: 10.1177/1758834014567117 |
0.311 |
|
| 2015 |
Alese OB, Kim S, Chen Z, Owonikoko TK, El-Rayes BF. Management patterns and predictors of mortality among US patients with cancer hospitalized for malignant bowel obstruction. Cancer. 121: 1772-8. PMID 25739854 DOI: 10.1002/Cncr.29297 |
0.351 |
|
| 2015 |
Steuer CE, Behera M, Kim S, Patel N, Chen Z, Pillai R, Saba NF, Shin DM, Owonikoko TK, Khuri FR, Ramalingam SS. Predictors and outcomes of venous thromboembolism in hospitalized lung cancer patients: A Nationwide Inpatient Sample database analysis. Lung Cancer (Amsterdam, Netherlands). 88: 80-4. PMID 25726042 DOI: 10.1016/J.Lungcan.2015.01.022 |
0.323 |
|
| 2015 |
Owonikoko TK, Ramalingam SS, Miller DL, Force SD, Sica GL, Mendel J, Chen Z, Rogatko A, Tighiouart M, Harvey RD, Kim S, Saba NF, Pickens A, Behera M, Fu RW, et al. A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1859-68. PMID 25673697 DOI: 10.1158/1078-0432.Ccr-14-1998 |
0.322 |
|
| 2015 |
Barbee MS, Nooka A, Kaufman JL, Kim S, Chen Z, Heffner LT, Lonial S, Harvey RD. Predictors of survival outcomes in phase 1 relapsed or refractory multiple myeloma patients. Cancer. 121: 853-62. PMID 25377852 DOI: 10.1182/Blood.V122.21.1958.1958 |
0.301 |
|
| 2015 |
Geiger C, Chen Z, Zhang C, Behera M, Steuer CE, Pillai RN, Ramalingam SS. Investigating the correlation between disease burden and symptoms in patients with advanced stage lung cancer. Journal of Clinical Oncology. 33: e19057-e19057. DOI: 10.1200/Jco.2015.33.15_Suppl.E19057 |
0.335 |
|
| 2015 |
Alese OB, Kim S, Chen Z, Shaib WL, Owonikoko TK, El-Rayes BF. Management and outcomes of hospitalized patients with primary neuroendocrine tumor (NET) and non-NET appendiceal cancers in the United States. Journal of Clinical Oncology. 33: e17722-e17722. DOI: 10.1200/Jco.2015.33.15_Suppl.E17722 |
0.307 |
|
| 2015 |
Shaib WL, Qu J, Zhang C, Ip A, Chen Z, El-Rayes BF, Alese O. Borderline resectable (BRPC) and locally advanced unresectable (LAPC) pancreas cancer treatment: A single Institution experience. Journal of Clinical Oncology. 33: e15260-e15260. DOI: 10.1200/Jco.2015.33.15_Suppl.E15260 |
0.353 |
|
| 2015 |
Alese OB, Kim S, Chen Z, Owonikoko TK, El-Rayes BF. Pattern of liver-directed therapies and outcomes in cancer patients hospitalized in the United States. Journal of Clinical Oncology. 33: e15112-e15112. DOI: 10.1200/Jco.2015.33.15_Suppl.E15112 |
0.31 |
|
| 2015 |
MOHAMED A, Schrapp K, Owonikoko TK, Steuer CE, Chen Z, Pakkala S, Pillai RN, Wadsworth JT, Higgins KA, Ramalingam SS, Beitler JJ, Shin DM, Khuri FR, Behera M, Saba NF. Concurrent chemoradiation using weekly versus tri-weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck (SCCHN): A comparative analysis. Journal of Clinical Oncology. 33: 6055-6055. DOI: 10.1200/Jco.2015.33.15_Suppl.6055 |
0.322 |
|
| 2015 |
Owonikoko TK, Harvey RD, Lewis C, Chen Z, Kauh JS, Renfroe M, Deovic R, Sica GL, Carthon BC, Harris WB, El-Rayes BF, Ramalingam SS, Khuri FR. Abstract CT303: A phase I pharmacokinetic and pharmacodynamic evaluation of the combination of everolimus and buparlisib for concurrent mTOR and PI3K pathway blockade in patients with advanced solid tumors Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ct303 |
0.375 |
|
| 2015 |
Wang X, Beitler JJ, Huang W, Qian G, Magliocca K, Zhang J, Nannapaneni S, Kim S, Chen Z, Nabil SF, Chen ZG, Arbiser JL, Shin DM. Abstract 20: Honokiol radiosensitizes squamous cells carcinoma of head and neck by down-regulation of survivin Cancer Research. 75: 20-20. DOI: 10.1158/1538-7445.Am2015-20 |
0.363 |
|
| 2014 |
Saba NF, Hurwitz SJ, Magliocca K, Kim S, Owonikoko TK, Harvey D, Ramalingam SS, Chen Z, Rogerio J, Mendel J, Kono SA, Lewis C, Chen AY, Higgins K, El-Deiry M, et al. Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck. Cancer. 120: 3940-51. PMID 25103371 DOI: 10.1002/Cncr.28965 |
0.331 |
|
| 2014 |
Behera M, Owonikoko TK, Kim S, Chen Z, Higgins K, Ramalingam SS, Shin DM, Khuri FR, Beitler JJ, Saba NF. Concurrent therapy with taxane versus non-taxane containing regimens in locally advanced squamous cell carcinomas of the head and neck (SCCHN): a systematic review. Oral Oncology. 50: 888-94. PMID 25060589 DOI: 10.1016/J.Oraloncology.2014.06.014 |
0.325 |
|
| 2014 |
Jiang N, Wang D, Hu Z, Shin HJ, Qian G, Rahman MA, Zhang H, Amin AR, Nannapaneni S, Wang X, Chen Z, Garcia G, MacBeath G, Shin DM, Khuri FR, ... ... Chen ZG, et al. Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma. Molecular Cancer Therapeutics. 13: 1826-36. PMID 24748655 DOI: 10.1158/1535-7163.Mct-13-1093 |
0.309 |
|
| 2014 |
Hawk NN, Long TE, Imam MH, Mathew BM, Kim S, Chen Z, Goodman M, Sullivan P, Brutcher E, Kauh J, Maithel SK, Adsay VN, Farris AB, Staley C, El-Rayes BF. Clinicopathologic Features and Outcome of Young Adults With Stage IV Colorectal Cancer. American Journal of Clinical Oncology. PMID 24662267 DOI: 10.1097/01.Coc.0000437899.28701.03 |
0.329 |
|
| 2014 |
Chen Z, Cui Y, Owonikoko TK, Wang Z, Li Z, Luo R, Kutner M, Khuri FR, Kowalski J. Escalation with overdose control using all toxicities and time to event toxicity data in cancer Phase I clinical trials. Contemporary Clinical Trials. 37: 322-32. PMID 24530487 DOI: 10.1016/J.Cct.2014.02.004 |
0.326 |
|
| 2014 |
Majumdar D, Jung KH, Zhang H, Nannapaneni S, Wang X, Amin AR, Chen Z, Chen ZG, Shin DM. Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity. Cancer Prevention Research (Philadelphia, Pa.). 7: 65-73. PMID 24403290 DOI: 10.1158/1940-6207.Capr-13-0230 |
0.315 |
|
| 2014 |
Shaib WL, Sharma R, Brutcher E, Kim S, Maithel SK, Chen Z, Kooby DA, Kauh J, Landry J, El-Rayes BF. Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma. Journal of Surgical Oncology. 109: 556-60. PMID 24338561 DOI: 10.1002/Jso.23529 |
0.338 |
|
| 2014 |
Saba NF, Hurwitz SJ, Kono SA, Yang CS, Zhao Y, Chen Z, Sica G, Müller S, Moreno-Williams R, Lewis M, Grist W, Chen AY, Moore CE, Owonikoko TK, Ramalingam S, ... ... Chen ZG, et al. Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study. Cancer Prevention Research (Philadelphia, Pa.). 7: 283-91. PMID 24085777 DOI: 10.1158/1940-6207.Capr-13-0215 |
0.339 |
|
| 2014 |
Saba NF, Magliocca KR, Kim S, Muller S, Chen Z, Owonikoko TK, Sarlis NJ, Eggers C, Phelan V, Grist WJ, Chen AY, Ramalingam SS, Chen ZG, Beitler JJ, Shin DM, et al. Acetylated tubulin (AT) as a prognostic marker in squamous cell carcinoma of the head and neck. Head and Neck Pathology. 8: 66-72. PMID 23881549 DOI: 10.1007/S12105-013-0476-6 |
0.367 |
|
| 2014 |
Steuer CE, Behera M, Kim S, Patel N, Chen Z, Pillai RN, Saba NF, Shin DM, Owonikoko TK, Khuri FR, Ramalingam SS. Predictors and outcomes of venous thromboembolism (VTE) in hospitalized lung cancer patients: A nationwide inpatient sample (NIS) database analysis. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E17632 |
0.324 |
|
| 2014 |
Behera M, Steuer CE, Kim S, Pillai RN, Chen Z, Owonikoko TK, Belani CP, Khuri FR, Ramalingam SS. Management approaches and outcomes of lung cancer patients hospitalized for malignant pleural effusions. Journal of Clinical Oncology. 32: 9646-9646. DOI: 10.1200/Jco.2014.32.15_Suppl.9646 |
0.317 |
|
| 2014 |
Alese OB, Kim S, Chen Z, Owonikoko TK, El-Rayes BF. Mortality from malignant bowel obstruction in hospitalized U.S. cancer patients. Journal of Clinical Oncology. 32: 9626-9626. DOI: 10.1200/Jco.2014.32.15_Suppl.9626 |
0.323 |
|
| 2014 |
Behera M, Ragin C, Kim S, Chen Z, Steuer CE, Saba NF, Pillai RN, Belani CP, Ramalingam SS, Khuri FR, Owonikoko TK. Trends in small cell lung cancer (SCLC) survival: Predictors and impact of systemic therapy. Journal of Clinical Oncology. 32: 7599-7599. DOI: 10.1200/Jco.2014.32.15_Suppl.7599 |
0.323 |
|
| 2014 |
Steuer CE, Behera M, Kim S, Chen Z, Pillai RN, Owonikoko TK, Khuri FR, Ramalingam SS. Clinical characteristics and outcomes of atypical carcinoid (AC) tumor of the lung: A Surveillance, Epidemiology, and End Results database analysis. Journal of Clinical Oncology. 32: 7554-7554. DOI: 10.1200/Jco.2014.32.15_Suppl.7554 |
0.366 |
|
| 2014 |
Pooja C, Nooka AK, Chatwal MS, Kim S, Chen Z, Kowalski J, Kaufman JL, Lonial S, Bernal-Mizrachi L. Outcomes for Myeloma in the Era of Lenalidomide Maintenance Are Not Different Among Ethnic Groups Following Autologous Transplant Blood. 124: 3973-3973. DOI: 10.1182/Blood.V124.21.3973.3973 |
0.37 |
|
| 2014 |
Bernal-Mizrachi L, Nooka AK, Pooja C, Chatwal MS, Kim S, Chen Z, Kowalski J, Kaufman JL, Lonial S. Racial Disparity in Patients with Multiple Myeloma Are Blunted in the Era Novel Therapies Blood. 124: 2525-2525. DOI: 10.1182/Blood.V124.21.2525.2525 |
0.359 |
|
| 2014 |
Owonikoko TK, Lewis C, Busari AK, Kim S, Chen Z, Lawson DH, Carthon BC, El-Rayes BF, Khuri FR, Kauh J, Harvey RD, Ramalingam SS. Abstract C26: Ethnic, gender, and age disparities and outcome of phase I clinical trials of biologically targeted anticancer agents Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C26 |
0.357 |
|
| 2014 |
Owonikoko TK, Zhang G, Sica GL, Chen Z, Switchenko JM, Kim S, Gal AA, Ramalingam SS, Deng X, Rossi MR, Kowalski J, Khuri FR. Abstract 922: Evaluating markers of cisplatin sensitivity and survival in small cell lung cancer Cancer Research. 74: 922-922. DOI: 10.1158/1538-7445.Am2014-922 |
0.365 |
|
| 2014 |
Wang X, Qian X, Beitler JJ, Zhang J, Kang H, Chen Z(, Magliocca KR, Wang X, Chen Z, Nie S, Shin DM. Abstract 4829: Evaluation prognostic significance of circulating tumor cells (CTCs) using multiplexed gold nanoparticles in patients with head and neck cancer Cancer Research. 74: 4829-4829. DOI: 10.1158/1538-7445.Am2014-4829 |
0.335 |
|
| 2014 |
Wang D, Qin X, Qian G, Halig L, Fei B, Chen Z, Chen ZG, Saba NF, Shin DM, Xu H, Wang AY. Abstract 3223: EGFR targeted iron-oxide nanoparticles for photodynamic therapy in head and neck cancer Cancer Research. 74: 3223-3223. DOI: 10.1158/1538-7445.Am2014-3223 |
0.307 |
|
| 2013 |
Wang Y, Zhang S, Iqbal S, Chen Z, Wang X, Wang YA, Liu D, Bai K, Ritenour C, Kucuk O, Wu D. Pomegranate extract inhibits the bone metastatic growth of human prostate cancer cells and enhances the in vivo efficacy of docetaxel chemotherapy. The Prostate. PMID 24375421 DOI: 10.1002/Pros.22769 |
0.337 |
|
| 2013 |
Owonikoko TK, Chowdry RP, Chen Z, Kim S, Saba NF, Shin DM, Khuri FR. Clinical efficacy of targeted biologic agents as second-line therapy of advanced thyroid cancer. The Oncologist. 18: 1262-9. PMID 24153240 DOI: 10.1634/Theoncologist.2013-0250 |
0.358 |
|
| 2013 |
Mahaseth H, Brutcher E, Kauh J, Hawk N, Kim S, Chen Z, Kooby DA, Maithel SK, Landry J, El-Rayes BF. Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinoma. Pancreas. 42: 1311-5. PMID 24152956 DOI: 10.1097/Mpa.0B013E31829E2006 |
0.307 |
|
| 2013 |
Zhang S, Wang Y, Chen Z, Kim S, Iqbal S, Chi A, Ritenour C, Wang YA, Kucuk O, Wu D. Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells. The Prostate. 73: 1681-9. PMID 23999913 DOI: 10.1002/Pros.22705 |
0.317 |
|
| 2013 |
Eaton BR, Kim S, Marcus DM, Prabhu R, Chen Z, Ramalingam SS, Curran WJ, Higgins KA. Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer. Cancer. 119: 3753-60. PMID 23921891 DOI: 10.1002/Cncr.28267 |
0.371 |
|
| 2013 |
D'Marco LG, Bellasi A, Kim S, Chen Z, Block GA, Raggi P. Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 28: 2586-95. PMID 23904396 DOI: 10.1093/Ndt/Gft264 |
0.304 |
|
| 2013 |
Tarbell NJ, Friedman H, Polkinghorn WR, Yock T, Zhou T, Chen Z, Burger P, Barnes P, Kun L. High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2936-41. PMID 23857975 DOI: 10.1200/Jco.2012.43.9984 |
0.335 |
|
| 2013 |
Owonikoko TK, Ragin C, Chen Z, Kim S, Behera M, Brandes JC, Saba NF, Pentz R, Ramalingam SS, Khuri FR. Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis. The Oncologist. 18: 600-10. PMID 23635558 DOI: 10.1634/Theoncologist.2012-0480 |
0.347 |
|
| 2013 |
Shi Z, Das S, Okwan-Duodu D, Esiashvili N, Flowers C, Chen Z, Wang X, Jiang K, Nastoupil LJ, Khan MK. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 86: 569-77. PMID 23540349 DOI: 10.1016/J.Ijrobp.2013.02.007 |
0.303 |
|
| 2013 |
Ramalingam SS, Owonikoko TK, Behera M, Subramanian J, Saba NF, Kono SA, Gal AA, Sica G, Harvey RD, Chen Z, Klass CM, Shin DM, Fu H, Sun SY, Govindan R, et al. Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 8: 369-72. PMID 23407561 DOI: 10.1097/Jto.0B013E318282709C |
0.406 |
|
| 2013 |
Prajapati HJ, Dhanasekaran R, El-Rayes BF, Kauh JS, Maithel SK, Chen Z, Kim HS. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma. Journal of Vascular and Interventional Radiology : Jvir. 24: 307-15. PMID 23375519 DOI: 10.1016/J.Jvir.2012.11.026 |
0.352 |
|
| 2013 |
Harvey R, Owonikoko T, Lewis CM, Akintayo A, Chen Z, Tighiouart M, Ramalingam S, Fanucchi M, Nadella P, Rogatko A, Shin D, El-Rayes B, Khuri F, Kauh J. A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies British Journal of Cancer. 108: 762-765. PMID 23322195 DOI: 10.1038/Bjc.2012.604 |
0.304 |
|
| 2013 |
Eaton BR, McDonald MW, Kim S, Marcus RB, Sutter AL, Chen Z, Esiashvili N. Radiation therapy target volume reduction in pediatric rhabdomyosarcoma: implications for patterns of disease recurrence and overall survival. Cancer. 119: 1578-85. PMID 23280478 DOI: 10.1002/Cncr.27934 |
0.325 |
|
| 2013 |
Sun X, Li J, Sica G, Fan SQ, Wang Y, Chen Z, Muller S, Chen ZG, Fu X, Dong XY, Guo P, Shin DM, Dong JT. Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma. Head & Neck. 35: 1007-14. PMID 22791392 DOI: 10.1002/Hed.23077 |
0.355 |
|
| 2013 |
Zafar SF, Patil DH, Kauh JS, Adsay V, Brutcher E, Maithel SK, Wang Z, Chen Z, El-Rayes BF. Neuroendocrine tumors (NET) of the gastrointestinal tract: Patterns of management and experience at Winship Cancer Institute of Emory University. Journal of Clinical Oncology. 31: 326-326. DOI: 10.1200/Jco.2013.31.4_Suppl.326 |
0.364 |
|
| 2013 |
Behera M, Pillai RN, Owonikoko TK, Kim S, Chen Z, Saba NF, Belani CP, Khuri FR, Ramalingam SS. Bevacizumab in combination with taxane versus non-taxane-containing regimens for advanced/metastatic nonsquamous non-small-cell lung cancer (NSCLC): A systematic review. Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.E19094 |
0.348 |
|
| 2013 |
Shaib WL, Sharma R, Kim S, Chen Z, Kauh JS, Kooby DA, Maithel SK, Landry JC, El-Rayes BF. Survival outcome of ampullary and duodenal adenocarcinomas. Journal of Clinical Oncology. 31: e14579-e14579. DOI: 10.1200/Jco.2013.31.15_Suppl.E14579 |
0.335 |
|
| 2013 |
Shi ZJ, Das S, Okwan-Duodu D, Esiashvili N, Flowers C, Jiang K, Chen Z, Wang X, Curran WJ, Khan MK. Patterns of failure in advanced-stage diffuse large B-cell lymphoma (DLBCL) patients treated with R-CHOP chemotherapy and the emerging role of consolidative radiotherapy. Journal of Clinical Oncology. 31: 8546-8546. DOI: 10.1200/Jco.2013.31.15_Suppl.8546 |
0.337 |
|
| 2013 |
Eaton BR, Marcus DM, Kim S, Chen Z, Ramalingam SS, Curran WJ, Higgins K. Prophylactic cranial irradiation in patients ≥ 70 years old with limited stage small cell lung cancer: A Surveillance, Epidemiology, and End Results analysis. Journal of Clinical Oncology. 31: 7589-7589. DOI: 10.1200/Jco.2013.31.15_Suppl.7589 |
0.369 |
|
| 2013 |
Kang H, Kim S, Chen Z, El-Rayes BF, Brandes JC, Saba NF, Khuri FR, Ramalingam SS, Owonikoko TK. A retrospective cohort study of inpatient chemotherapy utilization in hospitalized advanced lung cancer patients in the United States. Journal of Clinical Oncology. 31: 6611-6611. DOI: 10.1200/Jco.2013.31.15_Suppl.6611 |
0.378 |
|
| 2013 |
Saba NF, Kono SA, Mendel JR, Hurwitz SJ, Owonikoko TK, Lewis CM, Harvey D, Rogerio JW, Chen Z, Wadsworth T, El-Deiry M, Chen AY, Higgins K, Ramalingam SS, Beitler JJ, et al. Carboplatin (C), cetuximab (Cet), and everolimus (E) in recurrent or metastatic squamous cell carcinoma of the head and neck (RMSCCHN). Results of a phase Ib study. Journal of Clinical Oncology. 31: 6083-6083. DOI: 10.1200/Jco.2013.31.15_Suppl.6083 |
0.351 |
|
| 2013 |
Jiang N, Wang D, Hu Z, Rahman AM, Zhang H, Amin RA, Wang X, Chen Z, Dong SM, Garcia G, MacBeath G, Ma J, Khuri FR, Saba NF, Chen GZ. Abstract LB-79: Combined treatment with HER3 antibody MM-121/SAR 256212 and EGFR antibody cetuximab in pre-clinical models of head and neck cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-79 |
0.345 |
|
| 2013 |
Owonikoko TK, Miller DL, Force S, Sica G, Kono S, Behera M, Mendel J, Chen Z, Pickens A, Fu RW, Auffermann WF, Rogerio J, Torres WE, Fu H, Hohneker J, et al. Abstract LB-194: Window of opportunity preoperative interrogation of mTOR pathway in patients with resectable non-small cell lung cancer (NSCLC). Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-194 |
0.39 |
|
| 2013 |
Joshi JP, Chen Z, Nahta R. Abstract 889: Growth differentiation factor 15 causes increased invasiveness and EMT in HER2-overexpressing breast cancer via activation of p38 MAPK. Cancer Research. 73: 889-889. DOI: 10.1158/1538-7445.Am2013-889 |
0.307 |
|
| 2013 |
Webber G, Chen Z, El-Rayes B, Kauh J, Spivey J, Hanish S, Kim H. Update with longitudinal analysis of quality of life assessment after doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE) in patients with hepatocellular carcinoma (HCC) Journal of Vascular and Interventional Radiology. 24: S141. DOI: 10.1016/J.Jvir.2013.01.349 |
0.3 |
|
| 2012 |
Wang D, Müller S, Amin AR, Huang D, Su L, Hu Z, Rahman MA, Nannapaneni S, Koenig L, Chen Z, Tighiouart M, Shin DM, Chen ZG. The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4589-99. PMID 22829201 DOI: 10.1158/1078-0432.Ccr-11-3127 |
0.334 |
|
| 2012 |
Muringampurath-John D, Jaye DL, Flowers CR, Saxe D, Chen Z, Lechowicz MJ, Weisenburger DD, Bast M, Arellano ML, Bernal-Mizrachi L, Heffner LT, McLemore M, Kaufman JL, Winton EF, Lonial S, et al. Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase. British Journal of Haematology. 158: 608-14. PMID 22758202 DOI: 10.1111/J.1365-2141.2012.09209.X |
0.328 |
|
| 2012 |
Owonikoko TK, Behera M, Chen Z, Bhimani C, Curran WJ, Khuri FR, Ramalingam SS. A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 866-72. PMID 22722788 DOI: 10.1097/Jto.0B013E31824C7F4B |
0.356 |
|
| 2012 |
Chen Z, Tighiouart M, Kowalski J. Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials. Contemporary Clinical Trials. 33: 949-58. PMID 22561391 DOI: 10.1016/J.Cct.2012.04.007 |
0.314 |
|
| 2012 |
Arellano M, Pakkala S, Langston A, Tighiouart M, Pan L, Chen Z, Heffner LT, Lonial S, Winton E, Khoury HJ. Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia. Cancer. 118: 5278-82. PMID 22517268 DOI: 10.1002/Cncr.27494 |
0.309 |
|
| 2012 |
Sencer SF, Zhou T, Freedman LS, Ives JA, Chen Z, Wall D, Nieder ML, Grupp SA, Yu LC, Sahdev I, Jonas WB, Wallace JD, Oberbaum M. Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group. Bone Marrow Transplantation. 47: 1409-14. PMID 22504933 DOI: 10.1038/Bmt.2012.30 |
0.307 |
|
| 2012 |
Rahman MA, Amin AR, Wang X, Zuckerman JE, Choi CH, Zhou B, Wang D, Nannapaneni S, Koenig L, Chen Z, Chen ZG, Yen Y, Davis ME, Shin DM. Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth. Journal of Controlled Release : Official Journal of the Controlled Release Society. 159: 384-92. PMID 22342644 DOI: 10.1016/J.Jconrel.2012.01.045 |
0.314 |
|
| 2012 |
Xu J, Müller S, Nannapaneni S, Pan L, Wang Y, Peng X, Wang D, Tighiouart M, Chen Z, Saba NF, Beitler JJ, Shin DM, Chen ZG. Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer. European Journal of Cancer (Oxford, England : 1990). 48: 1682-91. PMID 22341992 DOI: 10.1016/J.Ejca.2011.12.029 |
0.33 |
|
| 2012 |
Pakkala S, Chen Z, Rimland D, Owonikoko TK, Gunthel C, Brandes JR, Saba NR, Shin DM, Curran WJ, Khuri FR, Ramalingam SS. Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy. Cancer. 118: 164-72. PMID 21713759 DOI: 10.1002/Cncr.26242 |
0.313 |
|
| 2012 |
Gilman AL, Schultz KR, Goldman FD, Sale GE, Krailo MD, Chen Z, Langholz B, Jacobsohn DA, Chan KW, Ryan RE, Kellick M, Neudorf SM, Godder K, Sandler ES, Sahdev I, et al. Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 18: 84-91. PMID 21689773 DOI: 10.1016/J.Bbmt.2011.05.016 |
0.32 |
|
| 2012 |
Mahaseth H, Kauh JS, Brutcher E, Hawk NN, Kim S, Chen Z, El-Rayes BF. Safety and efficacy of modified FOLFIRINOX in pancreatic cancer: A retrospective experience. Journal of Clinical Oncology. 30: e14614-e14614. DOI: 10.1200/Jco.2012.30.15_Suppl.E14614 |
0.384 |
|
| 2012 |
Park W, Vallabhaneni GD, Martin LK, Adsay V, Staley CA, Maithel SK, Wang Z, Chen Z, El-Rayes BF, Bekaii-Saab TS. Clinicopathologic feature and outcome of appendiceal goblet cell carcinoid and neuroendocrine tumor. Journal of Clinical Oncology. 30: e14170-e14170. DOI: 10.1200/Jco.2012.30.15_Suppl.E14170 |
0.351 |
|
| 2012 |
Bekaii-Saab TS, Martin LK, Vallabhaneni GD, Park W, Staley CA, Maithel SK, Wang Z, Chen Z, El-Rayes BF. A comparative analysis of locoregional therapy (hyperthermic intraperitoneal chemotherapy [HIPEC]) and systemic chemotherapy (CT) following cytoreductive surgery in patients (pts) with disseminated mucinous appendiceal cancers (MACA). Journal of Clinical Oncology. 30: e14169-e14169. DOI: 10.1200/Jco.2012.30.15_Suppl.E14169 |
0.311 |
|
| 2012 |
Chowdry RP, Sica G, Chen Z, Goodman A, Kim S, Deng X, Curran WJ, Gal AA, Khuri FR, Ramalingam SS, Owonikoko TK. Expression pattern and biologic relevance of Bcl-2 and Mcl-1 in pulmonary neuroendocrine tumors. Journal of Clinical Oncology. 30: 7097-7097. DOI: 10.1200/Jco.2012.30.15_Suppl.7097 |
0.332 |
|
| 2012 |
Behera M, Beitler JJ, Bhimani C, Higgins K, Chen Z, Kim S, Deng X, Curran WJ, Khuri FR, Ramalingam SS, Owonikoko TK. A systematic analysis of high-dose radiation in the treatment of surgically unresectable, locally advanced non-small cell lung cancer. Journal of Clinical Oncology. 30: 7059-7059. DOI: 10.1200/Jco.2012.30.15_Suppl.7059 |
0.357 |
|
| 2012 |
Saba NF, Magliocca KR, Kim S, Muller S, Chen Z, Eggers C, Phelan VH, Kono SA, Owonikoko TK, Ramalingam SS, Grist W, Chen AY, Beitler JJ, Shin DM, Marcus A, et al. Acetylated tubulin and risk of nodal metastases in squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 30: 5560-5560. DOI: 10.1200/Jco.2012.30.15_Suppl.5560 |
0.355 |
|
| 2012 |
Owonikoko TK, Harvey RD, Kauh JS, Lewis CM, Hossain MS, Akintayo AO, Merriewether AR, Chen Z, Hawk NN, Saba NF, Harris W, Shin DM, El-Rayes BF, Huang C, Lonial S, et al. A phase I study of the safety and pharmacodynamic effects of everolimus in combination with lenalidomide in patients with advanced solid malignancies. Journal of Clinical Oncology. 30: 2576-2576. DOI: 10.1200/Jco.2012.30.15_Suppl.2576 |
0.348 |
|
| 2012 |
Wang X, Beitler JJ, Hong HW, Lee MJ, Chen Z, Koenig L, Amin ARR, Chen Z(, Arbiser JL, Shin DM. Abstract 1994: Honokiol reduces drug resistance by down-regulation of survivin expression in multidrug resistant squamous cell carcinoma of the head and neck Cancer Research. 72: 1994-1994. DOI: 10.1158/1538-7445.Am2012-1994 |
0.321 |
|
| 2011 |
Khuri FR, Owonikoko TK, Subramanian J, Sica G, Behera M, Saba NF, Chen Z, Tighiouart M, Shin DM, Sun S, Fu R, Gal A, Govindan R, Ramalingam SS. Everolimus, an mTOR inhibitor, in combination with docetaxel for second- or third-line therapy of advanced-stage non-small cell lung cancer: A phase II study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e13601. PMID 28023520 DOI: 10.1200/Jco.2011.29.15_Suppl.E13601 |
0.358 |
|
| 2011 |
Owonikoko TK, Behera M, Tran HN, Chen Z, Chowdry RP, Saba NF, Ramalingam SS, Khuri FR. Systematic comparative analysis of efficacy of EGFR tyrosine kinase inhibitors (TKIs) in the frontline versus salvage therapy of NSCLC. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 7602. PMID 28023322 DOI: 10.1200/Jco.2011.29.15_Suppl.7602 |
0.32 |
|
| 2011 |
Hossain S, Bhimani C, Chen Z, Ramalingam SS, Shin DM, Cohen C, Khuri FR, Waller E, Owonikoko TK. Comparison of native and adaptive immunity profiles of healthy volunteers and patients with well-differentiated thyroid cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5585. PMID 28022083 DOI: 10.1200/Jco.2011.29.15_Suppl.5585 |
0.321 |
|
| 2011 |
Arellano M, Bernal-Mizrachi L, Pan L, Tighiouart M, Souza L, Guo X, McLemore M, Lima L, Sunay S, Heffner LT, Chen Z, Chen GZ, Langston A, Winton E, Khoury HJ. Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia. Clinical Lymphoma, Myeloma & Leukemia. 11: 427-32. PMID 21729688 DOI: 10.1016/J.Clml.2011.03.035 |
0.306 |
|
| 2011 |
Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, Chen Z, Müller S, Chen Z, Josson S, Coleman IM, Nelson PS, Wang YA, Wang R, Shin DM, Marshall FF, et al. EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis. Oncogene. 30: 4941-52. PMID 21625216 DOI: 10.1038/Onc.2011.199 |
0.333 |
|
| 2011 |
Edgerton N, Sirintrapun SJ, Munoz M, Chen Z, Osunkoya AO. Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 24 cases. International Journal of Urology : Official Journal of the Japanese Urological Association. 18: 49-54. PMID 21114685 DOI: 10.1111/J.1442-2042.2010.02672.X |
0.318 |
|
| 2011 |
Oliva IV, Smith SL, Chen Z, Osunkoya AO. Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion: does extent of stromal invasion significantly impact patient outcome? Human Pathology. 42: 51-6. PMID 20870265 DOI: 10.1016/J.Humpath.2010.06.013 |
0.304 |
|
| 2011 |
Zhang H, Nannapaneni S, Chen Z, Saba N, Khuri FR, Chen G(, Shin DM. Abstract 841: Inhibition of head and neck squamous cell carcinoma growth by combination treatment of erlotinib and celecoxib: Potential chemopreventive agents Cancer Research. 71: 841-841. DOI: 10.1158/1538-7445.Am2011-841 |
0.36 |
|
| 2011 |
Harris WB, Lingerfelt BM, Chen Z, Kucuk O, Osunkoya AO, Pattaras JG, Ogan K, Nieh PT, Petros JA, Young AN, Marshall FF, Master V. Abstract 5169: Simple perioperative algorithm for serum C-reactive protein: A potent, independent, adverse prognostic factor for renal cell carcinoma Cancer Research. 71: 5169-5169. DOI: 10.1158/1538-7445.Am2011-5169 |
0.343 |
|
| 2011 |
Sun X, Li J, Sica G, Fan S, Wang Y, Chen Z, Muller S, Chen ZG, Shin DM, Dong J. Abstract 4004: Mislocalization of ATBF1 is associated with progression of head and neck squamous cell carcinoma Cancer Research. 71: 4004-4004. DOI: 10.1158/1538-7445.Am2011-4004 |
0.349 |
|
| 2010 |
Pappo AS, Krailo M, Chen Z, Rodriguez-Galindo C, Reaman G. Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 5011-6. PMID 20956621 DOI: 10.1200/Jco.2010.31.2603 |
0.32 |
|
| 2010 |
Beaty O, Berg S, Blaney S, Malogolowkin M, Krailo M, Knight R, Schaiquevich P, Stewart C, Chen Z, Nelson M, Voss S, Ivy SP, Adamson PC. A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study. Pediatric Blood & Cancer. 55: 440-5. PMID 20658614 DOI: 10.1002/Pbc.22544 |
0.358 |
|
| 2010 |
Chen Z, Krailo MD, Azen SP, Tighiouart M. A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials. Contemporary Clinical Trials. 31: 473-82. PMID 20609419 DOI: 10.1016/J.Cct.2010.05.010 |
0.493 |
|
| 2010 |
Vogt AP, Chen Z, Osunkoya AO. Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding? Human Pathology. 41: 1339-44. PMID 20573373 DOI: 10.1016/J.Humpath.2010.03.005 |
0.338 |
|
| 2010 |
Pakkala S, Chen Z, Rimland D, Owonikoko TK, Gunthel C, Brandes JC, Saba NF, Curran WJ, Khuri FR, Ramalingam SS. HIV-associated lung cancer in the era of highly active antiretroviral therapy (HAART): Correlation between CD4 count and outcome. Journal of Clinical Oncology. 28: 7632-7632. DOI: 10.1200/Jco.2010.28.15_Suppl.7632 |
0.331 |
|
| 2010 |
Harvey RD, Kauh JS, Ramalingam SS, Lewis CM, Chen Z, Lonial S, Blount IC, Shin DM, Khuri FR, Owonikoko TK. Combination therapy with sunitinib and bortezomib in adult patients with radioiodine refractory thyroid cancer. Journal of Clinical Oncology. 28: 5589-5589. DOI: 10.1200/Jco.2010.28.15_Suppl.5589 |
0.373 |
|
| 2010 |
Saba NF, Marcus A, Beitler JJ, Muller S, Eggers C, Grist W, Chen A, Chen Z, Shin DM, Khuri FR. Abstract 3744: Acetylated tubulin (AT) levels predicts response to TPF chemotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC) Cancer Research. 70: 3744-3744. DOI: 10.1158/1538-7445.Am10-3744 |
0.404 |
|
| 2010 |
Wang D, Wang Y, Amin ArmR, Su L, Muller S, Huang D, Nannapaneni S, Koenig L, Chen Z, Pan L, Tighiouart M, Shin DM, Chen Z(. Abstract 2333: Integrin β1 contributes to metastasis and prognosis of squamous cell carcinoma of the head and neck (HNSCC) Cancer Research. 70: 2333-2333. DOI: 10.1158/1538-7445.Am10-2333 |
0.331 |
|
| 2009 |
Katzenstein HM, Chang KW, Krailo M, Chen Z, Finegold MJ, Rowland J, Reynolds M, Pappo A, London WB, Malogolowkin M. Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group. Cancer. 115: 5828-35. PMID 19813275 DOI: 10.1002/Cncr.24667 |
0.37 |
|
| 2009 |
Chou AJ, Kleinerman ES, Krailo MD, Chen Z, Betcher DL, Healey JH, Conrad EU, Nieder ML, Weiner MA, Wells RJ, Womer RB, Meyers PA. Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. Cancer. 115: 5339-48. PMID 19637348 DOI: 10.1002/Cncr.24566 |
0.353 |
|
| 2009 |
Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 53: 1016-22. PMID 19588519 DOI: 10.1002/Pbc.22088 |
0.312 |
|
| 2009 |
Chen Z, Krailo MD, Sun J, Azen SP. Range and trend of expected toxicity level (ETL) in standard A + B designs: a report from the Children's Oncology Group. Contemporary Clinical Trials. 30: 123-8. PMID 19000782 DOI: 10.1016/J.Cct.2008.10.006 |
0.498 |
|
| 2009 |
DuBois SG, Krailo MD, Lessnick SL, Smith R, Chen Z, Marina N, Grier HE, Stegmaier K. Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group. Pediatric Blood & Cancer. 52: 324-7. PMID 18989890 DOI: 10.1002/Pbc.21822 |
0.35 |
|
| 2009 |
Muringampurath-John D, Flowers CR, Jabbar AA, Sinha R, Arellano M, Bernal-Mizrachi L, Kaufman JL, Jaye DL, Chen Z, Lechowicz MJ, Lonial S, Armitage JO, Khoury HJ. Prognostic Significance of Circulating Lymphoma Cells in Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL). Blood. 114: 2947-2947. DOI: 10.1182/Blood.V114.22.2947.2947 |
0.327 |
|
| 2008 |
Goldsby R, Burke C, Nagarajan R, Zhou T, Chen Z, Marina N, Friedman D, Neglia J, Chuba P, Bhatia S. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort. Cancer. 113: 2597-604. PMID 18823030 DOI: 10.1002/Cncr.23860 |
0.369 |
|
| 2008 |
Leavey PJ, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Brown K, Tarbell N, Bernstein ML, Granowetter L, Gebhardt M, Grier HE. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group. Pediatric Blood & Cancer. 51: 334-8. PMID 18506764 DOI: 10.1002/Pbc.21618 |
0.339 |
|
| 2008 |
Malogolowkin MH, Katzenstein HM, Krailo M, Chen Z, Quinn JJ, Reynolds M, Ortega JA. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2379-83. PMID 18467729 DOI: 10.1200/Jco.2006.09.7204 |
0.359 |
|
| 2008 |
Fujii H, Cuvelier G, She K, Aslanian S, Shimizu H, Kariminia A, Krailo M, Chen Z, McMaster R, Bergman A, Goldman F, Grupp SA, Wall DA, Gilman AL, Schultz KR. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood. 111: 3276-85. PMID 17925486 DOI: 10.1182/Blood-2007-08-106286 |
0.315 |
|
| 2007 |
Miser JS, Goldsby RE, Chen Z, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore SG, Rausen AR, et al. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group. Pediatric Blood & Cancer. 49: 894-900. PMID 17584910 DOI: 10.1002/Pbc.21233 |
0.326 |
|
| 2007 |
Seibel NL, Krailo M, Chen Z, Healey J, Breitfeld PP, Drachtman R, Greffe B, Nachman J, Nadel H, Sato JK, Meyers PA, Reaman GH. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943. Cancer. 109: 1646-53. PMID 17334983 DOI: 10.1002/Cncr.22553 |
0.348 |
|
| 2007 |
Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, Rausen AR, Robison LL, Vietti TJ, Miser JS. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood. 109: 46-51. PMID 16985182 DOI: 10.1182/Blood-2006-01-023101 |
0.327 |
|
| 2007 |
Leavey P, Mascarenhas L, Marina N, Chen Z, Krailo M, Miser J, Bernstein M, Granowetter L, Grier H. Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence Journal of Clinical Oncology. 25: 10011-10011. DOI: 10.1200/Jco.2007.25.18_Suppl.10011 |
0.344 |
|
| 2006 |
Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2879-84. PMID 16782927 DOI: 10.1200/Jco.2005.02.6013 |
0.387 |
|
| 2006 |
Miralbell R, Fitzgerald TJ, Laurie F, Kessel S, Glicksman A, Friedman HS, Urie M, Kepner JL, Zhou T, Chen Z, Barnes P, Kun L, Tarbell NJ. Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. International Journal of Radiation Oncology, Biology, Physics. 64: 1325-30. PMID 16413699 DOI: 10.1016/J.Ijrobp.2005.11.002 |
0.357 |
|
| 2006 |
Goldsby R, Burke C, Nagarajan R, Zhou T, Chen Z, Inskip P, Marina N, Friedman D, Neglia J, Bhatia S. Solid organ second malignant neoplasms among children diagnosed with malignant bone tumors treated on Children Cancer Study Group/Pediatric Oncology Group protocols after 1980 Journal of Clinical Oncology. 24: 9007-9007. DOI: 10.1200/Jco.2006.24.18_Suppl.9007 |
0.373 |
|
| 2005 |
Choe MS, Tighiouart M, Rogatko A, Muller S, Shin HJ, Francisco M, Papadimitrakopoulou VA, Khuri FR, Hong WK, Chen Z, Shin DM. Role of cyclooxygenase-2 (COX-2) expression in tumor progression and survival in the squamous cell carcinoma of the head and neck (HNSCC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5508. PMID 27945462 DOI: 10.1200/Jco.2005.23.16_Suppl.5508 |
0.347 |
|
| 2005 |
Zhang X, Choe MS, Lee JE, Muller S, Tighiouart M, Rogatko A, Glisson BS, Chen Z, Khuri FR, Shin DM. GRIM-19 expression and its correlation with clinical outcomes of an induction chemotherapy for patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5519. PMID 27945215 DOI: 10.1200/Jco.2005.23.16_Suppl.5519 |
0.326 |
|
| 2005 |
Greenberg ML, Fisher PG, Freeman C, Korones DN, Bernstein M, Friedman H, Blaney S, Hershon L, Zhou T, Chen Z, Kretschmar C. Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatric Blood & Cancer. 45: 644-8. PMID 16110498 DOI: 10.1002/Pbc.20382 |
0.349 |
|
| 2005 |
Nicholson HS, Zhou T, Chen Z, Moran K, Sklar C, Zeltzer L, Neglia J. Quality of Life in Survivors of Childhood and Adolescent Acute Myelogenous Leukemia (AML) Does Not Differ by Treatment (Bone Marrow Transplant (BMT) vs. Chemotherapy). A Report from the Children’s Oncology Group (COG). Blood. 106: 701-701. DOI: 10.1182/Blood.V106.11.701.701 |
0.304 |
|
| Show low-probability matches. |